Genmab — November 2018
-
Stanford-firmas tidlige forsøg fjerner alle tegn på genstridig kræft hos otte patienter
Biotekselskabet Forty Seven, som udspringer af forskning på Stanford University, har haft succes i et fase 1-studie, hvor alle tegn på en ellers tilbagevendende blodkræftsygdom forsvandt hos otte ud af 22 patienter.
(medwatch.dk)
-
Skulle man have en time til overs i dag, så kan man se Jans oplæg til Aarhus Symposium I fredags her https://getvisualtv.net/stream/?Aarhus-Symposium-2018-1
-
@solsen, nummer fire fra toppen
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
